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Abstract
The Dot/Icm system of the intracellular pathogen Legionella pneumophila has the capacity to deliver over 270 effector
proteins into host cells during infection. Important questions remain as to spatial and temporal mechanisms used to
regulate such a large array of virulence determinants after they have been delivered into host cells. Here we investigated
several L. pneumophila effector proteins that contain a conserved phosphatidylinositol-4-phosphate (PI4P)-binding domain
first described in the effector DrrA (SidM). This PI4P binding domain was essential for the localization of effectors to the early
L. pneumophila-containing vacuole (LCV), and DrrA-mediated recruitment of Rab1 to the LCV required PI4P-binding activity.
It was found that the host cell machinery that regulates sites of contact between the plasma membrane (PM) and the
endoplasmic reticulum (ER) modulates PI4P dynamics on the LCV to control localization of these effectors. Specifically,
phosphatidylinositol-4-kinase IIIa (PI4KIIIa) was important for generating a PI4P signature that enabled L. pneumophila
effectors to localize to the PM-derived vacuole, and the ER-associated phosphatase Sac1 was involved in metabolizing the
PI4P on the vacuole to promote the dissociation of effectors. A defect in L. pneumophila replication in macrophages
deficient in PI4KIIIa was observed, highlighting that a PM-derived PI4P signature is critical for biogenesis of a vacuole that
supports intracellular multiplication of L. pneumophila. These data indicate that PI4P metabolism by enzymes controlling
PM-ER contact sites regulate the association of L. pneumophila effectors to coordinate early stages of vacuole biogenesis.
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Introduction
Intracellular pathogens co-opt host processes to facilitate
pathogen survival and replication within the eukaryotic host. To
do this, many bacterial pathogens possess secretion systems that
transport bacterial proteins into host cells to orchestrate their
intracellular survival. After uptake by phagocytic host cells, the
gram-negative bacterium Legionella pneumophila prevents transport
of the vacuole in which it resides through the canonical endocytic
pathway, and actively transforms this vacuole into an organelle
that supports bacterial replication. Specifically, endoplasmic
reticulum (ER)- derived vesicles are rapidly recruited to the
plasma membrane (PM) -derived vacuole in which L. pneumophila
resides after uptake by host cells [1]. These early secretory vesicles
originating from the ER appear to fuse with the L. pneumophila
vacuole [2–4]. Functional interactions between PM-localized t-
SNAREs present on the L. pneumophila-containing vacuole (LCV)
and ER-localized SNARE Sec22b likely contribute towards this
remodeling process [5,6].
Effector proteins delivered by the Dot/Icm secretion system
contribute to trafficking and remodeling of the vacuole containing
L. pneumophila. The protein DrrA (also known as SidM) is an
effector with guanine nucleotide exchange factor (GEF) activity
that directly activates the host GTPase Rab1 [7,8]. Rab1 is an
important regulator of membrane transport in the early secretory
pathway of eukaryotic cells [9]. The GEF domain of DrrA (amino
acids 340–533) is necessary for recruitment of Rab1 to LCVs
[7,8,10–12]. Recent data indicate that activation of Rab1 on the L.
pneumophila-containing vacuole is sufficient for promoting the
tethering and fusion of ER-derived vesicles with this plasma
membrane-derived organelle [13].
DrrA is found associated with the LCV membrane within the
first hour of infection, but dissociates from the LCV at roughly
4 hours post-infection, which is when remodeling of the LCV to
an ER-like organelle is evident [1,10,14,15]. The temporal
association of DrrA on the LCV membrane illustrates how the
timing, localization and function of effector proteins is likely to be
important for coordinating events that mediate biogenesis of the
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specialized vacuole in which L. pneumophila replicates. This is
further demonstrated by the discovery of additional proteins that
tightly regulate Rab1 recruitment and function during L.
pneumophila infection. After Rab1 is recruited onto the early LCV
by the GEF activity of DrrA, Rab1 function is modulated by L.
pneumophila effectors that posttranslationally modify the switch II
region of the GTPase. Rab1 is AMPylated by an adenylyltransfer-
ase domain located in a domain at the amino terminus of DrrA
protein or phosphocholinated by the effector protein AnkX
[16,17]. These modifications appear to affect Rab1 function by
limiting interactions with several host cell proteins that associate
with Rab1 [18,19]. A de-AMPylase activity associated with the
effector SidD was found to remove the AMP moiety from Rab1
[14,20,21] and the protein Lem3 has a dephosphocholination
activity that can remove the phosphocholine moiety from Rab1
[22]. These effectors render Rab1 susceptible to inactivation by
the effector LepB, which facilitates removal of Rab1 from the
mature LCV [14]. It is believed that the activities of these proteins
are coordinately regulated in vivo by spatial cues that signify
changes in vacuole morphology, but the cellular signaling
mechanisms controlling these processes remain poorly understood.
Spatial localization of DrrA in host cells involves a C-terminal
region of the protein that possesses phosphatidylinositol 4-
phosphate (PI4P)-binding activity [8,23–26]. Phosphatidylinositol
phosphates (PIPs) are negatively charged phospholipids displayed
on the cytosolic face of cellular membranes. Production of
specific PIP species is spatially and temporally regulated by
kinases and phosphatases, and the seven different PIP species
are considered markers of specific cellular compartments.
Importantly, these PIPs act as regulators of cellular processes
due to their ability to aid in the targeting of PIP-binding
proteins to discrete membrane surfaces within cells [27–30].
Numerous conserved domains have been shown to confer
specific PIP binding properties to proteins [31]. These include
pleckstrin homology (PH), FYVE (acronym of Fab1, YOTB,
Vac1 and EEA1), and phox homology (PX) domains. Domains
shown to bind to PI4P include PH, Tom1 (GAT), and epsin N-
terminal homology (ENTH).
An increasing number of bacterial pathogens possess effectors
that are able to mimic host enzymes involved in generation of
specific host phosphoinositides required to facilitate bacterial
survival by modulation of cellular membranes utilized by the
pathogen [32,33]. Vacuoles containing L. pneumophila isolated from
the protozoan host Dictyostelium discoideum stain positive with an
anti-PI4P antibody and with a GST-FAPP1 PH domain-contain-
ing probe [34], and the effector SidC that also binds to PI4P in vitro
localizes to vacuoles during infection [35]. Thus, it is likely that
PI4P is an important determinant that regulates the activities of
both host and effector proteins on the LCV, including DrrA.
However, the precise role PI4P plays in modulating effector
localization and the origin of the PI4P residing on the LCV
membrane remain unclear. The L. pneumophila effector protein
SidF, which has lipid phosphatase activity [36], is a bacterial
determinant that participates in PIP metabolism. In vitro assays
demonstrated that SidF can hydrolyse the D3 phosphate of
PI(3,4)P2 and PI(3,4,5)P3, which would facilitate PI4P production.
Indeed, it was found that DsidF mutant L. pneumophila reside in
vacuoles with reduced levels of SidC association, which supports
the hypothesis that SidF has a role in maintaining PI4P levels on
the LCV membrane.
Although the Golgi apparatus is the most prominent organelle
staining positive for PI4P, the PM, ER and endosomes also
contain PI4P [37]. Control of PI4P production is achieved by the
subcellular distribution of phosphatidylinositol 4-kinases, which
based on sensitivities to adenosine and wortmannin are grouped as
type II and type III, respectively [38,39]. The levels of PI4P on
specific compartments is further regulated by the conversion
of PI4P to PI(3,4)P2 or PI(4,5)P2 by specific kinases, and by
dephosphorylation of PI(4,5)P2 to PI4P or PI4P to PI by
phosphatases. Although progress has been made in determining
the roles of PIP-metabolizing enzymes in the generation of specific
pools of PI4P, most of the known PI4P-binding probes primarily
localize to the Golgi-apparatus [40–43]. This abundant pool of
PI4P is largely generated by the cis/medial Golgi-localized
PI4KIIIb (encoded by PI4KB and Pik1 in mammals and yeast,
respectively) [44–46]. Because the majority of PI4P probes target
the Golgi-localized pool of PI4P it has been difficult to track the
outcome of perturbation, by chemical inhibition or siRNA
knockdown, of PI-phosphatases or kinases on less abundant pools
of PI4P. Despite this challenge several groups have demonstrated
that PI4P is an important determinant at the PM [38,47], and
identified the host kinase PI4KIIIa (encoded by PI4KA and Stt4
in mammals and yeast, respectively) as important for generation
of the PM pool of PI4P in eukaryotes [38,40,48]. In yeast Stt4
has been reported to localize at phosphoinositide kinase (PIK)
patches that are stable cortical membrane sites enriched in Stt4
[49]. These sites have been proposed to reside at membrane
contact sites linked to the ER to coordinate lipid transfer and
signaling events between these two organelles [49,50]. In
support of this, after interaction with oxysterol-binding homol-
ogy (Osh) proteins, which act as sensors of PI4P levels, the ER-
localized Sac1 phosphatase acts in trans at ER-plasma mem-
brane contact sites to reduce PM PI4P levels [51]. In
mammalian cells ER-localization of PI4KIIIa was reported
[46], but recent direct visualization studies have show localiza-
tion of PI4KIIIa at the PM [48].
Importantly, the PI4P-binding domain of DrrA localizes to
the PM when expressed ectopically [8], suggesting that L.
pneumophila effectors may have evolved to recognize this PM-
localized pool of PI4P and that this signature may be used for
the localization of effectors to the LCV membrane. Thus, we set
out here to investigate the in vivo role for this effector-encoded
PI4P binding domain in an effort to understand the origin and
function of PI4P during L. pneumophila vacuole transport, and to
determine if L. pneumophila subverts the host machinery used to
maintain PI4P levels in the cell to temporally regulate effector
localization.
Author Summary
The intracellular pathogen Legionella pneumophila en-
codes at least 270 effectors that modulate trafficking of the
pathogen-occupied vacuole. The mechanisms by which
effectors are controlled in host cells are of key interest.
Spatial and temporal regulation of effector function has
been proposed to involve effector binding to host
phosphoinositides. We present results showing that L.
pneumophila utilizes the host kinase PI4KIIIa to generate
PI4P on the bacterial vacuole and this signature mediates
the localization of DrrA and subsequent recruitment of the
GTPase Rab1. Additionally, it was found that the host PI4P
phosphatase Sac1 was involved in consuming PI4P on the
vacuole, which reduced DrrA-mediated recruitment of
Rab1 to the LCV. Our data supports the recent concept
that PI4KIIIa is important for generation of the plasma-
membrane pool of PI4P in host cells, and demonstrates a
functional consequence for PI4P-binding by an L. pneu-
mophila effector protein.
PI4KIIIa-Mediated Spatial Regulation of Effectors
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Results
Lpg1101 and Lpg2603 have a domain that constitutes a
conserved Legionella Effector PI4P-binding Region (LEPR)
The L. pneumophila proteins Lpg1101 and Lpg2603 were
predicted to have a C-terminal region that was highly similar to
the C-terminal region in DrrA, and amino terminal regions with
no significant amino acid homology to proteins of known function
(Figure 1A). A calmodulin-dependent adenylate cyclase (Cya)
assay was used to show that both Lpg1101 and Lpg2603 could be
delivered into host cells by the L. pneumophila Dot/Icm system,
suggesting these proteins are both effectors (Figure S1A). When
these proteins were aligned, two regions were identified with a very
high degree of amino acid identity to residues in the DrrA PI4P-
binding site (Figure 1B). Unlike DrrA, the effector Lpg1101 did
not bind to Rab1 in vitro, consistent with the homology between the
two proteins being outside of any known Rab-interacting regions
(Figure S1B). Consistent with the PI4P-binding activity of DrrA
being contained in this region of homology, both Lpg1101 and
Lpg2603 showed specific binding of PI4P using in vitro lipid
binding assays (Figure 1C). Thus, all three effector proteins have a
C-terminal region that mediates PI4P binding, which means that
this domain constitutes a conserved Legionella Effector PI4P-
binding Region (LEPR).
To assess whether the LEPR effectors affect L. pneumophila
intracellular growth or possess redundant functions during
infection, mutants lacking the individual effectors or the triple
mutant D1101D2603DdrrA were assessed. Mutants were not
found to have an impact on intracellular replication in THP-1
cells, murine bone marrow-derived macrophages or amoeba
(Figure S2).
The LEPR confers effector localization to PM-derived
structures
Previous data indicated that the LEPR of DrrA mediates
localization of the protein to the PM of host cells [8]. We
confirmed that amino acids 501–647 of DrrA were sufficient for
PM localization when ectopically expressed in host cells (Figure
S1C). This localization pattern was somewhat unexpected
considering that many proteins with PI4P-binding domains
localize primarily to the Golgi apparatus. To determine whether
PM localization is a general feature of effectors containing a
LEPR, the localization of Lpg1101 and Lpg2603 was examined
(Figure 2A panel 1, S1D and S1E). Indeed, PM localization was
observed for both effectors. In addition to mediating PI4P binding,
the LEPR of DrrA also mediates an interaction with PM-localized
syntaxins [13], which could contribute to DrrA localization to the
PM. As shown previously, the LEPR region of DrrA co-
immunoprecipitated with PM syntaxins Stx2, Stx3 and Stx4
(Figure S3A), but Lpg1101 or Lpg2603 did not co-precipitate with
PM syntaxins (Figure S3B). Unlike DrrA, Lpg1101 and Lpg2603
did not mediate recruitment of Rab1 to the PM, consistent with
Lpg1101 and Lpg2603 having no homology to the Rab1-binding
region in the GEF domain of DrrA (Figure S3C). Mutations were
introduced into highly conserved amino acids in the LEPRs to
determine if these residues were critical for PM localization (Figure
S4). Conservative substitutions (DRE and KRR) corresponding
to D565 and K568 in DrrA were made in DrrA, Lpg1101, and
Lpg2603; and alanine substitutions were made to conserved
residues found in the PI4P-binding pocket of DrrA corresponding
to K568 and T619. These mutations perturbed membrane
targeting for all three effectors (Figure 2A). Localization to the
PM as determined by fluorescence microscopy was affected by
these mutations, and cell fractionation studies indicated that these
mutations affected the distribution of each protein from the
membrane fraction to the cytosolic fraction (Figure 2B). Impor-
tantly, the DRE and KRR mutations in DrrA, Lpg1101 and
Lpg2603 perturbed binding of the purified His-tagged effectors to
PI4P on immobilized lipid arrays (Figure 2C). Thus, the conserved
residues in the LEPR are required for PI4P binding and are
important for interactions between these effector proteins and
lipids on the host PM.
In addition to binding PI4P, structural studies have identified a
membrane insertion motif (MIM) that is comprised of conserved
polar residues lining the PI4P binding pocket in the LEPR domain
[52]. In vitro studies have shown that upon PI4P binding the MIM
region contacts acyl chains in the core of the lipid membrane,
which stabilizes the interaction between the LEPR domain and
liposomes displaying PI4P. To address whether membrane
penetration by the MIM domain is important for PM localization
in vivo we tested LEPR domain mutant proteins in which
conserved leucine residues in the MIM domain were substituted
for alanine (Figure 3, Figure S5, S6). Single and double amino acid
substitutions L610A, L617A and L614A/L615A in the MIM
domain of DrrA retained PM localization. The triple mutant
L610A/L614A/L614A was localized primarily to the cytosol,
however, some peripheral localization was still detected (Figure
S5). A second DrrA triple mutant defective in three MIM domain
leucine residues L614A/L615A/L617A and a quadruple MIM
mutant L610A/L614A/615A/L617A displayed cytoplasmic lo-
calization (Figure S5). Likewise, an Lpg1101 quadruple MIM
mutant L288A/V292A/T293A/I295A displayed cytoplasmic
localization (Figure 3, Figure S6). Systematic analysis of each of
lysine residues within the MIM domain of Lpg2603 was not
performed because it was found that a single L405A substitution
was sufficient to shift the localization of the Lpg2603 LEPR
domain from the PM to the cytosol. This was in contrast to the
DrrA- and Lpg1101-LEPR domains with single or double
substitutions in MIM domain residues, which did not result in a
profound defect in PM localization. Thus, these data indicate that
membrane penetration by the MIM domain contributes to PM
localization of LEPR domain-containing effectors.
PI4P binding is important for the in vivo function of DrrA
Although an important role for the LEPR can be inferred from
data showing this region is sufficient for PI4P binding in vitro, it is
unknown whether PI4P binding is critical for the functioning of
LEPR-containing effectors in vivo. Thus, assays that measure DrrA
localization and function were used to address this question. The
effector DrrA demonstrates strong localization to LCVs at 1 hour
after infection of mammalian cells [7,8,10] and PI4P has been
identified on LCVs isolated from Dictyostelium using both PI4P-
specific antibodies and the PI4P-binding protein FAPP1 [34].
Consistent with data in Dictyostelium, we observed localization of
GFP-FAPP1 to vacuoles containing wild type L. pneumophila in
mammalian cells at 1 hour post-infection, but not vacuoles
containing a DdotA mutant (Figure S7A); and GFP-FAPP1R18L,
which is deficient in PI4P binding [53], was not observed in
association with LCVs (Figure S7B). Thus, DrrA and PI4P are
both displayed on vacuoles containing wild type L. pneumophila at
1 hour post-infection in mammalian cells.
Importantly, DrrA was detected by immunofluorescence
microscopy on vacuoles containing wild type L. pneumophila and
on vacuoles containing a DdrrA strain complemented with wild
type drrA on a plasmid; however, DrrA staining was not observed
on vacuoles containing the DdrrA strain complemented with the
mutant alleles drrAD565E,K568R or drrAK568R,T619A (Figure S8A).
Rab1 staining was conducted after infection to determine whether
PI4KIIIa-Mediated Spatial Regulation of Effectors
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a defect in association of DrrA with the vacuole correlates with a
defect in Rab1 recruitment to the vacuole. At 1 hr post-infection,
.60% of the vacuoles containing wild type L. pneumophila stained
positive for Rab1 by a process that was dependent on Dot/Icm
function and on DrrA function. Rab1 recruitment to vacuoles was
restored when a plasmid-encoded allele of wild type drrA was used
to complement the DdrrA strain. By contrast, Rab1 recruitment
was not detected on vacuoles when plasmids encoding the
drrAD565E/K568R or drrAK568A/T619A alleles were used to comple-
ment the DdrrA strain (Figure 4, Figure S8B). These substitutions
confirm that PI4P-binding is required for DrrA function in vivo.
Importantly, these substitutions in the LEPR of DrrA did not
affect Rab1 binding activity or Dot/Icm-dependent delivery of
DrrA into the host cytosol during infection (Figure S8C,D). Thus,
DrrA-mediated recruitment of Rab1 to the LCV in vivo requires
both the PI4P-binding activity and MIM functions mediated by
the LEPR.
Effectors with a LEPR localize to the early LCV
The presence of PI4P on vacuolar membranes and the shared
targeting of the LEPR effectors to the plasma membrane suggest
that Lpg1101 and Lpg2603 will target the early LCV after uptake
Figure 1. A conserved Legionella-effector PI4P-binding region. (A) Schematic representation of the effector proteins DrrA, Lpg1101 and
Lpg2603. Indicated are regions correspond to the ATase (blue), GEF (yellow) and PI4P-binding domain (green) of DrrA. The C-terminal regions of
Lpg1101 and Lpg2603 (green) have homology to the PI4P-binding region in DrrA. Non-homologous regions of unknown function in Lpg1101
(brown) and Lpg2603 (pink) are indicated. (B) Alignment of the LEPR regions in DrrA, Lpg1101 and Lpg2603 reveals conserved amino acid residues
corresponding to the PI4P-binding pocket of DrrA (grey). (C) Binding of His-tagged DrrA, Lpg1101 and Lpg2603 to lipids immobilized on
nitrocellulose membranes was detected using an anti-His antibody. Template shows the location of specific lipids. All three proteins showed specific
binding to the spot containing PI4P. DAG, Diacylglycerol; PA, phosphatidic acid; PS, phosphatidyl serine; PE, phosphatidylethanolamine; PC,
phosphatidylcholine; PG, phosphatidylglycerol; PtdIns, phosphatidylinositol; PtdIns(4,5)P2, phosphatidylinositol 4,5 di-phosphate; PtdIns(3,4,5)P3,
phosphatidylinositol 3,4,5 tri-phosphate.
doi:10.1371/journal.ppat.1004222.g001
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Figure 2. A functional LEPR region is important for localization of effectors to the host PM. (A) Orthoview micrographs representative of
the localization of the indicated fluorescently tagged DrrA, Lpg1101 and Lpg2603 proteins in HEK293 cells. The large image contains a confocal xy-
section and the insert panel shows a z-section through the cell indicated by the intersection of the x-axis and y-axis lines. The three left panels show
the localization of the wild type (WT) protein, and the three right panels show the localization pattern observed for proteins having alanine
substitutions to the conserved lysine and threonine residues in the LEPR corresponding to positions K568 and T619 in DrrA (K-A, T-A mutant). Cells
were co-transfected with a plasmid producing an RFP-protein containing a palmitoylation sequence (RFP-PALM) to label the plasma membrane. (B)
Fractionation of HEK293 cells expressing GFP- or EYFP-tagged effector proteins shown in (A). Note the shift in the population of effectors from the
membrane fraction towards the cytosolic fraction in cells expressing the mutant versions of the effectors. A shift in the fractionation profiles is not
observed in the control blots for the membrane protein calnexin or the cytosolic marker protein alpha tubulin. P = pellet, C = cytosol, M=membrane.
(C) Lipid overlay experiment to determine the relative binding affinities of wild type LEPR-containing proteins versus proteins with mutations in their
LEPR domains. Hydrophobic membranes spotted with a concentration gradient of eight phosphoinositides (PIP arrays) were probed with the purified
His-tagged DrrA, Lpg1101, or Lpg2603 and LEPR mutant protein variants indicated. Bound protein was detected with an anti-His antibody.
doi:10.1371/journal.ppat.1004222.g002
PI4KIIIa-Mediated Spatial Regulation of Effectors
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by mammalian cells. To address this question, we first assessed
LCV localization of LEPR-containing effectors expressed ectop-
ically in host cells. Although PM localization was apparent in
transfected cells, we did not detect robust localization of 3X-
FLAG-DrrA or 3X-FLAG-Lpg2603 produced ectopically to
LCVs containing wild type L. pneumophila (data not shown),
however in cells producing 3X-FLAG-Lpg1101 we detected
circumferential staining around vacuoles containing L. pneumophila
at early time points post-infection and this staining dissipated as
the LCVs matured (Figure 5). Similar staining patterns were
observed in a stable HEK293 cell line producing 3X-FLAG-
Lpg1101 (Figure 5A) and during transient transfection of HeLa
cells with a plasmid producing YFP-Lpg1101 (Figure 5C). Using
the strong localization signal of Lpg1101 on early LCVs, the
importance of the PI4P-binding pocket and MIM regions for
vacuolar targeting of Lpg1101 was examined (Figure 5B,C).
Mutation of residues in both the PI4P-binding pocket and the
MIM domain disrupted the localization of Lpg1101 to the LCV.
These data confirm that the LEPR domain in Lpg1101 mediates
effector localization to the early LCV.
Localization of Lpg1101 and Lpg2603 produced endogenously
and translocated during L. pneumophila infection was examined by
indirect immunofluorescence using antibodies generated against
purified recombinant proteins (Figure S9). Immunoblot analysis
demonstrated that these antibodies detected plasmid-encoded
Lpg1101 and Lpg2603 produced from a constitutive promoter in
L. pneumophila (Figure S9A), however, endogenous Lpg1101 was
not detected in the infectious wild type L. pneumophila grown to
early stationary phase. A limited number of Lpg1101-positive
LCVs were observed 30 minutes after infection (Figure S9B),
however, staining was weak and could not be confirmed to be
specific. Thus, Lpg1101 may be produced at low levels or
regulated differently than Lpg2603, and additional studies aimed
at localization of Lpg1101 were not conducted.
Endogenously produced Lpg2603 was detected on LCVs
containing wild type L. pneumophila and was not detected on
Figure 3. Role of the Membrane Insertion Motif (MIM) in LEPR-containing effectors association with the PM. (A) Alignment of amino
acid region containing the exposed leucine residues of the MIM motif from DrrA with the similar region from the LEPR-domain containing effectors
Lpg1101 and Lpg2603. The key exposed residues are indicated with arrows. (B) Z-stack micrographs of confocal images of HEK293 cells expressing
GFP or EYFP-tagged fluorescent LEPR effectors and exposed leucine* to alanine mutants (*wild type exposed residues shown in red).
doi:10.1371/journal.ppat.1004222.g003
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Figure 4. Targeting of DrrA by PI4P-binding is functionally important during L. pneumophila infection because it is required for
localization of DrrA and Rab1 to Legionella-containing vacuoles. (A) Micrographs of HEK293 FccR cells infected with various Legionella
pneumophila Philadelphia-1 strains at 1 hour post-infection stained with Rab1b-specific antibodies and DAPI. Strains that do not produce DrrA
(DdrrA) or produce DrrA containing mutations that perturb PI4P-binding (DdrrA +pJBdrrA K568A/T619A) fail to show vacuolar Rab1b signals. (B)
PI4KIIIa-Mediated Spatial Regulation of Effectors
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vacuoles containing the DdotA mutant or the Dlpg2603 mutant
(Figure 6A, Figure S9C). The percent of vacuoles that stained
positive for Lpg2603 increased over time and maximal localization
was observed on mature vacuoles containing replicating L.
pneumophila (Figure 6B). Interestingly, infection of cells with L.
pneumophila Dlpg2603 producing the mutant Lpg2603K358A,T402A
protein revealed that this LEPR mutant retains the ability to
localize to the LCV at 6 hours post-infection (Figure S9C). Thus,
endogenous Lpg2603 translocated during infection localizes to the
LCV, however, localization of Lpg2603 to the mature LCV may
not require PI4P binding mediated by the LEPR domain.
Although the function of Lpg2603 remains unknown, ectopic
production of Lpg2603 in Saccharomyces cerevisiae interfered with
yeast replication by a process that required a functional LEPR
domain. A yeast growth defect was observed in cells expressing
Lpg2603 and Lpg2603 G354A, which localize to the PM in
mammalian cells, but not in yeast expressing the non-PM-
targeting Lpg2603 D355E,K358R mutant (Figure 6C,E, Figure
S3B). Similar levels of Lpg2603 expression were observed for all
Lpg2603-expressing yeast strains (Figure 6D). The growth
phenotype observed for Lpg2603 was weaker than that observed
for RalF and YlfA, effectors previously found to cause growth
defects in yeast. Taken together, these results suggest the PI4P-
binding domain of Lpg2603 is important for its function inside
eukaryotic cells.
Binding of DrrA to the PM requires a PIP signature
A permeabilized cell system was used to study the localization of
effectors with domains containing a LEPR (Figure S10). The
binding of purified His-tagged LEPR effectors was assessed using
HEK293 cells that had been permeabilized with digitonin, which
allows recombinant proteins to gain access to the cytosolic surface
of the PM and intracellular organelles. The His-LEPR effectors
were found at the PM with some detectable Golgi staining in the
permeabilized cells treated with His-DrrA. Peripheral localization
was not observed using purified His-SteC, a Salmonella effector, or
when His-DrrA mutant proteins that cannot bind PI4P were used
(Figure S10A,B). Pretreatment of the cells with ionomycin, a
calcium ionophore that stimulates hydrolysis of both PI4P and
PI(4,5)P2 in membranes [54], decreased localization of His-LEPR
effectors to the PM (Figure S10D). To further confirm the
requirement for PM PI4P in LEPR effector targeting to the PM we
utilized mouse embryonic fibroblasts (MEFs) derived from
conditional PI4KA knockout mice. Treatment of these cells with
(Z)-4-hydroxytamoxifen (TMX) causes cre-mediated deletion of
PI4KA, which encodes PI4KIIIa, and perturbs PM PI4P levels
[48]. Using our semi-intact assay we observed that TMX-
treatment caused a decrease in the levels of His-DrrA observed
at the PM, compared to control cells (Figure 7). A significant
change in Golgi morphology, determined by GRASP65 staining,
was not observed after deletion of PI4KA, which is consistent with
previous results [48]. His-DrrAD565E/K568R, which failed to bind to
PI4P in immobilized lipid arrays, showed weak localization to the
Golgi-apparatus in the presence or absence of functional
PI4KIIIa, likely due to Rab1-binding. Diminished PM localization
of His-Lpg1101 and His-Lpg2603 was also observed in TMX
treated compared to ethanol control MEFs from the conditional
PI4KA knockout mice (Figure 7B). As a comparison, we assessed
the localization of purified MBP-SidC609–776, which binds PI4P in
vitro [35]. This protein showed perinuclear localization in semi-
intact assays in HEK293 cells that was consistent with localization
to the Golgi apparatus (Figure S11). To test whether targeting of
MBP-SidC609–776 is influenced by PI4KIIIb we used the inhibitor
PIK93 at 1 mM concentration and observed a substantial
reduction in the perinuclear localization of SidC609–776. The
reported PIK93 IC50 values for PI3K, PI4KIIIa and PI4KIIIb
are 16 nM, 921–1620 nM, and 17.5–28 nM, respectively. A
substantial change in the plasma membrane localization of the
control MBP-Lpg2603134–434 was not observed after PIK93
treatment. These results further indicate that PI4P at the PM is
an important signature that is recognized by the LEPR in DrrA
and suggest PI4KIIIa is important for generating the PI4P that
mediates DrrA targeting to the PM.
Spatial control of DrrA function in vivo involves the
activity of PI4P metabolizing enzymes regulating ER/PM
contact sites
If DrrA recognizes a PI4P signature generated by PI4KIIIa,
then reducing PI4KIIIa in the host cells would limit DrrA
association with vacuoles containing L. pneumophila and interfere
with Rab1 recruitment to the LCV. To test this hypothesis, siRNA
was used to silence host PI4Ks and Rab1 recruitment to the LCV
was measured. Silencing of PI4KIIIa resulted in a significant
decrease in Rab1 recruitment to the LCV, whereas, silencing of
PI4KIIIb did not have a measurable effect on Rab1 recruitment to
the LCV (Figure 8A). RT-PCR to measure transcript levels
indicated that PI4KIIIa and PI4KIIIb were silenced to similar
levels in these cells; however, complete silencing was not obtained
(Figure S12C), which could explain why Rab1 recruitment to the
LCV in the PI4KIIIa-silenced cells was diminished but not
eliminated. Because the lipid phosphatase activity displayed by the
effector SidF generates PI4P through the hydrolysis of PI(3,4)P2
and PI(3,4,5)P3 a DsidF mutant was used to determine if this
effector was important for generating the PI4P signature used for
DrrA-mediated recruitment of Rab1 (Figure 8C). As reported
previously, we found reduced SidC localization to the LCV in cells
infected with the DsidF mutant compared to cells infected with the
isogenic control strain (Figure S12A). Rab1 recruitment to the
LCV was reduced in cells infected with the DsidF mutant, which
would be consistent with SidF being involved in PI4P production
on LCV. However, in DsidF-infected cells the levels of Rab1
recruitment to the LCV was even lower when PI4KIIIa was
silenced. Thus, our data indicate that PI4KIIIa and the activity of
SidF can independently produce a PI4P signature on the LCV that
enables DrrA to recruit Rab1 to the PM-derived organelle.
Recent evidence from studies in yeast indicates that PI4P is
metabolized at the PM through the coordinate functions of the
PI4KIIIa protein and the ER-localized PI4P phosphatase Sac1
[51,55]. Intriguingly, previous electron microscopy studies had
noted a distinct similarity between ER-PM contact sites and the
intimate association of ER-derived vesicles with the LCV [1], thus
suggesting Sac1 on ER-derived membranes may play a role in
consuming PI4P on the LCV in a manner similar to that used to
control PI4P levels at the PM. Indeed, a significant reduction in
the recruitment of Rab1 to the LCV was observed when the
human Sac1 phosphatase was overproduced in HEK293 FccRII
Quantification of Rab1b recruitment to LCVs with wild type, mutant and complemented L. pneumophila strains at various time points post-infection.
Vacuoles were stained for endogenous Rab1 recruitment using Rab1b specific antibody. At each time point 150 vacuoles were counted per strain
from three independent samples. Data shown are from one experiment but in at least two other independent experiments the same Rab1b
recruitment phenotypes were observed. Numbers shown above bars indicate percent infected.
doi:10.1371/journal.ppat.1004222.g004
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Figure 5. The effector Lpg1101 requires both its C-terminal LEPR and MIM regions for vacuolar localization. (A) Confocal micrograph
of HEK293 cells stably expressing both FccRII and 3XFLAG-tagged Lpg1101 and infected with wild type Lp01. The localization of 3xFLAG-tagged
Lpg1101 was detected by indirect immunofluorescence using indirect the affinity purified anti-Lpg1101 antibody (1:100) and secondary Alexa Fluor
488 (green). L. pneumophila were detected due to constitutive expression of mCherry (red). Lpg1101 was detected at both at the cell periphery and
surrounding Legionella. (B) Quantification of the localization of EYFP-tagged Lpg1101 and LEPR and MIM mutant variants with intracellular Lp01 at 30,
60 and 120 min post-infection. Amino acid substitutions are shown in red. (C) Fluorescent micrographs of the localization of EYFP-Lpg1101
(EYFP1101) and the LEPR (D243E/K246R) and MIM (L288A/V292A/T293A/I295A) variants in cells infected with mCherry expressing L. pneumophila
strain Lp01 (red). Hoechst 33343 was used to stain DNA (blue).
doi:10.1371/journal.ppat.1004222.g005
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cells by transient transfection (Figure 8B). These data suggest the
enzymes that regulate PI4P levels at sites of interaction between
the PM and ER regulate PI4P levels on the LCV, and the effector
protein DrrA responds to changes in PI4P levels controlled by
these enzymes.
PI4KIIIa is important for L. pneumophila infection
Macrophages derived from the bone marrow of mice having a
tamoxifen-inducible cre-mediated recombination system and an
allele of PI4KA flanked by loxP sites (PI4KAflox) were used to further
delineate the importance of PI4KIIIa during the intracellular
lifecycle of L. pneumophila. Macrophages were treated for seven
days with either tamoxifen to disrupt the PI4KA gene or with
ethanol as a vehicle control and then infected with L. pneumophila.
Macrophages were fixed 1 hr after infection and Rab1b staining
was used to assess the function of DrrA. Immunoblot analysis and
phosphoinositide measurement by HPLC revealed that tamoxifen-
treated macrophages derived from the PI4KAflox mice had a
reduction in the cellular levels of PI4KIIIa (Figure S12B, C).
Consistent with siRNA results, Rab1b recruitment to the LCV was
decreased significantly in macrophages from the PI4KAflox mice
treated with tamoxifen compared to macrophages from the same
mice treated with ethanol (Figure 9A, S12E). No defect in Rab1b
recruitment to the LCV was observed in macrophages derived
from control C57Bl/6 mice treated with either tamoxifen or
ethanol. There was no defect in Rab1b recruitment to the
LCV when PI4P levels were reduced through inhibition of
PI4KIIIb with PIK93 (Figure 9B). Because multiple effectors
contain a LEPR and utilize PI4P for localization to the LCV,
macrophages derived from the PI4KAflox mice were used to
determine if disrupting the PI4P signature generated by
PI4KIIIa might impact bacterial replication. These studies
revealed a significant defect in L. pneumophila replication in
tamoxifen-treated macrophages compared to the ethanol
control-treated macrophages from the PI4KAflox mice
(Figure 9C). Thus, generation of PI4P by PI4KIIIa is
important for the spatial regulation of L. pneumophila effectors
and disrupting PI4KIIIa has an adverse effect on replication of
L. pneumophila in macrophages.
Discussion
L. pneumophila must regulate the activity of at least 270 different
effector proteins to successfully coordinate distinct stages of
intracellular infection. Here we show that one mechanism used
to control the localization of early effectors containing PI4P-
binding domains is to utilize the host machinery at ER-PM contact
sites that is involved in regulating PI4P-levels on the PM. Our data
indicate that the host enzyme PI4KIIIa is involved in generating a
pool of PI4P that mediates the localization of multiple effectors
with a conserved PI4P-binding motif, and that the ER-localized
Sac1 phosphatase is capable of consuming this PI4P to stimulate
the dissociation of these effectors from the early LCV.
We report that multiple L. pneumophila Philadelphia-1 effectors
utilize a conserved LEPR domain that targets these proteins to
organelles derived from the plasma membrane. Previous studies
have shown that the LEPR in DrrA binds to PI4P in vitro [23], and
structural studies have identified a PI4P-binding pocket in this
region [24,25,52]. These structural studies revealed a positively-
charged pocket in the DrrA LEPR that mediates PI4P interac-
tions, and a negatively-charged surface patch predicted to orient
the protein for PI4P-binding. Many of these residues are
conserved in the LEPR of Lpg1101 and Lpg2603, and these
residues were critical for effector localization, as conservative
mutations in key residues shared between these proteins abrogated
both PM localization and in vitro-binding of these proteins to PI4P
on immobilized lipid arrays. Thus, we conclude that the PI4P-
binding activity displayed by these three effectors requires a
functional LEPR that mediates PM localization of the effectors.
Targeting of DrrA to PM-derived LCVs was dependent on
PI4P-binding, and directly correlated with the ability to recruit
Rab1 to this membrane. Structural data identified K568 as key for
interactions with the 4-phosphate of the bound ligand, and T619
as another key residue in the PI4P-binding pocket [25,52]. The
defect in localization of the DrrA K568A/T619A mutant to either
the PM or LCVs during infection confirms the importance of
PI4P-binding for the biological function of DrrA. These data
supports a model whereby DrrA binds to the LCV through a
process that requires recognition of PI4P on the vacuole
membrane and then recruits Rab1 by stimulating GDP for GTP
exchange [56].
Targeting of eukaryotic PI4P-binding proteins to specific
cellular compartments is typically facilitated by interactions with
other proteins. The proteins OSBP and FAPP are targeted to the
Golgi apparatus through both PI4P-binding determinants and by
interacting with the small GTPase Arf1 [42,53]. Recent data on
the dual interaction of FAPP1 with Arf1 and PI4P highlights the
emerging concept of coincidence detection in cell signaling [57].
How effectors containing a LEPR preferentially recognize a PM-
derived PI4P over another abundant pool of PI4P at the Golgi
remains an interesting question. Although the LEPR in DrrA has
been shown to interact with PM-localized syntaxin proteins [13],
the proteins Lpg1101 and Lpg2603 did not show similar
interactions, suggesting that host syntaxin proteins do not
constitute a common determinant that facilitates localization of
LEPR-containing effectors to the PM. It remains possible that
there are other host proteins that bind to the LEPR that facilitate
localization to the PM-derived organelle, or that there are other
properties of this organelle that are sensed by the LEPR that
confer specificity, such as membrane charge or lipid composition.
One such determinant is the membrane insertion motif (MIM)
region of DrrA [52].
Figure 6. Lpg2603 localizes to LCVs and its intracellular function requires the LEPR domain. (A) Fluorescent micrographs showing
colocalization of the effector Lpg2603, stained with affinity purified Lpg2603, and L. pneumophila, stained with DAPI, in bone marrow-derived
macrophages from A/J mice at 3 hours post-infection. Colocalization was not observed in infections with the Dlpg2603 or DdotA deletion strains
(lower panels). (B) Quantification of colocalization of Lpg2603 and intracellular L. pneumophila over early to mid phases of infection in HeLa cells. At
each time point, 100 Hoechst 33342 stained bacteria were assessed for the presence or absence of lpg2603 for each strain, and data represent the
average of results from three independent experiments. (C) Growth inhibition by ectopic production of Lpg2603 in yeast is restored by D355EK358A
mutation within the PI4P-binding domain. Shown are 10-fold serial dilutions of S. cerevisiae harboring either vector alone (pYES2) or plasmids
encoding YlfA, wild-type RalF protein, catalytically inactive RalF E103A mutant protein, Lpg2603, Lpg2603 mutants D355EK358A and G354A. Yeast
plating efficiency on medium containing glucose was compared to medium containing galactose. (D) Immunoblot analysis (anti-Lpg2603) of cellular
lysates from the indicated yeast strains shows equivalent levels of Lp2603 and mutants upon galactose induction. (E) Quantification of S. cerevisiae
growth in non-inducing (glucose) and inducing conditions (galactose). Values are relative to vector only controls and were calculated using Image J
software using two replicates for each condition.
doi:10.1371/journal.ppat.1004222.g006
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Figure 7. PI4KIIIa is important for localization of LEPR effectors to the PM. (A) Semi-intact assay showing the effects of deletion of PI4KIIIa
on localization of DrrA. Full length purified His-DrrA or His-DrrA D565E,K568R (5 mg/well) was added to digitonin treated immortalized mouse
embryonic fibroblasts (MEFs) containing (Z)-4-hydroxytamoxifen (TMX) inducible Cre-recombinase and floxed PI4KIIIa. Cells were either treated with
ethanol (control) or TMX (1.5 mM) for 2 days and then used 7 days later to assess DrrA localization. After washing away unbound protein, cells were
fixed with 4% PFA and His-tagged detected using a specific antibody at 1:500 (green). GRASP65 (red) and DAPI (blue) staining were used to visualize
the Golgi-apparatus and nucleus, respectively. (B) Semi-intact assay showing the effects of deletion of PI4KIIIa on localization of Lpg1101 and
Lpg2603. Experiment performed as in (A) using 5 mg/well His-tagged Lpg1101 and Lpg2603. For reference, fluorescent images of PI4P staining with
the anti-PI4P antibody from Echelon biosciences are shown in the lower panel.
doi:10.1371/journal.ppat.1004222.g007
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Based on the structure of the C-terminus of DrrA in complex
with dibutyl PI4P, helix 14 was predicted to penetrate phospho-
lipid membranes. Successive mutations of four key exposed
leucines in the MIM domain support this hypothesis as single
L610A and L617A mutants showed a 4–6 fold reduction in affinity
for PI4P-containing liposomes, and double (L614A/L615A) and
triple (L610A/L614A/L615A) mutants showed 91 and 440-fold
reduction in affinity, respectively [52]. Our data addressing the
importance of these leucine residues for targeting of DrrA to the
PM is consistent with the in vitro liposome affinity data. We
observed a correlation between the decrease in affinity for PI4P-
containing liposomes and the ability to target to the PM in
eukaryotic cells. Despite a marked decrease in affinity of the single
and double exposed leucine mutants for PI4P-containing lipo-
somes, our in vivo data showed only the most severely affected triple
and quadruple mutants failed to localize to the PM. This supports
the importance of the strong PI4P-binding affinity of DrrA
[24,52]. Although the mutant L610A/L614A/L615A showed a
shift in localization towards to cytoplasm, some peripheral
localization was observed. PM association was not observed in
the triple mutant (L614A/L615A/L617A) or in the quadruple
mutant. Structural analysis places lysine 617 in direct contact with
the acyl chains of the bound PI4P molecule, our data supports the
importance of this lysine for membrane association because the
phenotype for the L614A/L615A/L617A mutants is more severe
than the L610A/L614A/L615A triple mutant. Substitutions in
residues at conserved positions within Lpg1101 and Lpg2603 that
are likely exposed MIM-domain residues, were also found to be
important for plasma membrane localization of these effectors
supporting the importance of the MIM-domain for membrane
association. The effectors Lpg1101 and Lpg2603 do not show
substantial localization to the Golgi-apparatus irrespective of the
Figure 8. The host kinase PI4KIIIa is important for generation of a pool of PI4P used for DrrA targeting during infection. (A) Influence
of knockdown of PI4KIIIa and PI4KIIIb on DrrA-mediated recruitment of YFP-Rab1b to LCVs in HEK293 cells that stably express FccR and YFP-Rab1b.
After siRNA knockdown for 3 d, the HEK293 FccR YFP-Rab1b cells were infected with wild type L. pneumophila expressing dsRed for 1 h before
fixation. Quantification shown was obtained from at least 3 independent experiments with .300 vacuoles assessed for Rab1 recruitment for each
condition. (B) Graph showing the percentage of Rab1b-positive LCVs formed by L. pneumophila strain Lp02+pAM239, expressing GFP, at 30 min post-
infection in HEK293 FccRII cells transiently expressing the human Sac1p phosphatase or the vector control. Data is from three independent
experiments with .300 vacuoles assessed for Rab1 recruitment for each condition in each experiment. (C) Quantification of Rab1 colocalization with
L. pneumophila wild type or DsidF strains, constitutively expressing GFP from plasmid pAM239C, at 60 min post infection in HEK293 FccRII cells
transfected with non-targeting (mock) or siRNAs targeting PI4KIIIa at 3 days prior to infection.
doi:10.1371/journal.ppat.1004222.g008
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presence of the MIM domain, thus the MIM region is not the sole
determinant that directs these effectors to the plasma membrane
rather than the Golgi pool of PI4P. Although, the precise
mechanism for specific targeting of the LEPR effectors to the
plasma membrane pool of PI4P remains unknown it likely requires
several signals as has been observed for specific membrane
targeting of eukaryotic proteins to the plasma membrane [58].
Treating cells with PIK93, which is a potent and specific
inhibitor of PI4KIIIb, had no effect on DrrA function. Similarly,
no effect on DrrA function was observed when PI4KIIIb was
silenced by siRNA. These data are in contrast to what has been
observed in studies examining the localization of SidC to vacuoles
containing L. pneumophila [23]. The effector SidC also binds
membranes containing PI4P, however, the region of SidC
containing the predicted PI4P binding determinant has no amino
acid homology or predicted structural homology with the LEPR
[34,35]. This suggests that the mechanism of PI4P binding may be
different. Consistent with this hypothesis, it has been shown that
DrrA dissociates from the LCV shortly after bacterial replication
begins, whereas, the protein SidC remains localized to the mature
LCV [34]. When PI4KIIIb levels were reduced in Drosophila
Kc167 cells the amount of SidC associated with the LCV was
reduced, suggesting a role for this host protein in mediating SidC
localization [23]. The effector phosphatase SidF is one candidate
bacterial protein that could maintain a pool of PI4P recognized by
SidC during infection, which would be consistent with data
showing that an LCV formed by the DsidF mutant displays
reduced levels of SidC [36]. However, we found that the DsidF
Figure 9. Influence of PI4KIIIa knockout on DrrA-mediated recruitment of Rab1b to LCVs in bone-marrow derived macrophages
(BMM). (A) After treatment of BMM obtained from C57BL/6 or conditional PI4KAflox mice with either ethanol (EtOH) or (Z)-4-hydroxytamoxifen (TMX),
which induces cre-mediated deletion of floxed PI4KIIIa, BMM were infected with wild type L. pneumophila expressing GFP for 1 h before fixation.
Graph shows quantification of endogenous Rab1b recruitment to LCVs from three independent experiments with at least 150 vacuoles counted per
treatment (EtOH/TMX) and mouse donor (C57BL/6/PI4KAflox) for each experiment. (B) Quantification of endogenous Rab1b recruitment to LCVs
formed by Lp01+pAM239 in HEK293 FccRII at 1 hour post-infection in cells treated with either DMSO (control) or 2 mM PIK93. Drugs were added to
wells 30 min prior to infection and maintained throughout the subsequent steps. Data shown was obtained from 3 independent experiments with.
200 vacuoles assessed for Rab1 recruitment for each condition per experiment. (C) Graph showing fold-difference in colony forming units (CFU) of L.
pneumophila JR32DflaA at 48 hours post-infection compared to time zero. Results are from 18 wells from 2 inoculums per treatment (EtOH/TMX) and
mouse donor (C57BL/6/PI4KAflox) for each time point from one experiment. No statistical differences were observed between the separate inoculums
for each cell-type/treatment and results were averaged to give the final values. Error bars represent the SEM for fold-differences obtained for each
condition. A decrease in L. pneumophila replication in TMX-treated PI4KAflox BMDM was also observed in two additional independent experiments.
doi:10.1371/journal.ppat.1004222.g009
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mutant also reduced vacuolar levels of Rab1 suggesting both
PI4KIIIa and SidF function at early stages of infection to ensure
that the LCV membrane has a PI4P signature. These data could
indicate that LEPR effectors and SidC have different PI4P-binding
modalities, but there is some overlap in the proteins used to
generate and maintain the PI4P pools recognized by these
effectors.
In addition to generation of vacuolar PI4P by host kinases and
SidF, other mechanisms may further modulate PI on the L.
pneumophila phagosome. Whether other effector proteins exist with
PI-kinase or phosphatase activity is unknown, but the host
phosphatase OCRL has been reported to localize to the L.
pneumophila phagosome [59]. OCRL normally localizes to the
Golgi-apparatus, endosomes and the PM (after specific stimula-
tion) [60]. It possesses multiple protein-protein interaction
domains as well as a PH domain, and is proposed to function in
multiple membrane trafficking pathways, including between early
endosomes and the Golgi and clathrin-mediated endocytosis [60–
64]. The complexity of OCRL function is highlighted by the
multiple defects observed in patients with Lowe’s syndrome, which
have mutations in OCRL. Association of OCRL with membranes
occurs through interaction of active GTP-bound GTPases Rab1,
Rab5, Rab6 and Rab8, with the minimal Rab-binding domain
defined as amino acids 555–678 [65]. Although a mechanism for
recruitment of OCRL to LCVs through activated Rab GTPases is
possible, an N-terminal LVA (Legionella vacuole association)
domain of OCRL, which includes amino acids 1–236, is sufficient
for vacuolar association of OCRL. In Dictyostelium discoideum
deletion of the homologue of human OCRL Dd5P4 was reported
to show a number of phenotypes including reduced uptake,
enhanced trafficking and replication, as well as a reduction in SidC
recruitment to LCVs. This data suggests that the function of
OCRL is somehow deleterious for L. pneumophila, but the
molecular mechanisms behind these phenotypes are unknown.
Clearly, vacuolar PI4P-levels must be tightly controlled during
infection and mechanisms may be required to reduce vacuolar
PI4P-levels or remove OCRL from vacuoles at later stages of
infection. We found that the ER-localized PI4P phosphatase
protein Sac1 interfered with the association of LEPR effectors with
the LCV, supporting a role for these proteins in regulating the
PI4P signal detected by the LEPR to signal when the PM-derived
vacuoles have successfully been remodeled by ER-derived
membranes. Alternatively, the role of OCRL on LCVs may not
be simply PI4P production, but rather it may function in concert
with its other binding partners to mediate other processes that
influence vacuolar remodeling.
Pharmacological and genetic inhibitors indicated an important
role for PI4KIIIa in generating PI4P used for localization of these
effectors to the plasma membrane. These data provide support to
previous studies indicating a role for PI4KIIIa in generating PI4P
at the PM [40,48,66,67]. Our finding that PI4KIIIa is important
to generate the vacuolar PI4P recognized by the LEPR-containing
effectors supports a role for PI4KIIIa at the PM, but our results
cannot distinguish the subcellular localization of the kinase during
L. pneumophila infection. Contact between cortical ER and the PM
is reported to be less common in mammalian cells compared to
yeast [68], however, although recruitment of the LEPR-containing
proteins occurs before the LCV becomes positive for luminal ER
proteins, ER-derived vesicles associate with the LCV shortly after
uptake of the bacteria into the PM-derived phagosome [1]. It is
also possible that PI4KIIIa is directly co-opted by L. pneumophila to
enhance vacuolar PI4P levels.
Although we did not detect a defect in intracellular replication
in strains lacking all three of the LEPR-containing effectors, this
lack of growth defect is expected due to the redundant
mechanisms utilized by L. pneumophila to survive within host cells.
Our kinetic analysis suggests that Lpg1101 acts very early during
infection whereas Lpg2603 may function at several stages of the
infection process. The yeast growth defect observed upon
expression of Lpg2603 is consistent with a previously reported
yeast lethality phenotype for this effector, which may be due to
interference with the yeast secretory pathway [69]. The lack of a
growth defect for yeast expressing the Lpg2603 PI4P-binding
mutant suggests PI4P-targeting by Lpg2603 is functionally
important during infection. Determination of the host targets of
these effectors will allow future analysis of the importance of PI4-
binding in modulating the activities of these effectors.
These data suggest a model for spatial and temporal regulation
of effectors with a LEPR region. Upon L. pneumophila uptake,
LEPR-containing effectors would localize to the LCV membrane
through interactions with PI4P generated at the PM by PI4KIIIa.
For DrrA, this localization to the LCV membrane enables the
effector to recruit and activate Rab1 on the pathogen-occupied
organelle. Similarly, other LEPR-containing effectors are predict-
ed to have effector activities that are spatially regulated on the
early LCV. Shortly after formation, the LCV begins to recruit ER-
derived vesicles and the lipid composition of the PM-derived
organelle changes to become more similar to that of the host ER.
Our data indicate that the presence of the Sac1 phosphatase on
these ER-derived vesicles consumes the PI4P that is used for
binding of LEPR-containing effectors, and provides a signal to
indicate successful remodeling of the early LCV by ER-derived
vesicles. This would lead to dissociation of LEPR-containing
effectors from the LCV. When DrrA binding to the LCV is
abrogated, the balance in Rab1 dynamics would be shifted greatly
towards a pathway of Rab1 dissociation through the activity of the
L. pneumophila GAP protein LepB, an effector that has a
hydrophobic membrane spanning domain that anchors the
protein to the LCV membrane throughout the infection cycle.
Thus, these data highlight how spatial and temporal regulation of
L. pneumophila effectors is a sophisticated process controlled by both
intrinsic determinants such as PI4P-binding regions, and extrinsic
determinants such as host factors that generate the organelle-
specific signatures and the activity of other bacterial effectors that
have additional determinants that mediate spatial regulation.
Materials and Methods
Bacterial strains and plasmids
Bacterial strains, plasmids and primers are described in
supporting Text S1 (Tables S1–S3 in Text S1). L. pneumophila
strains were grown on charcoal-yeast extract plates or in aces-
buffered yeast extract broth as described previously [70]. All L.
pneumophila mutant strains described were constructed in the L.
pneumophila strain Lp01. Chromosomal deletion mutants were
made using the plasmid pSR47S as described previously [71]. L.
pneumophila Lp01 and mutant derivatives expressing the lux operon
of Photorhabdus luminescens were created by triparental mating of L.
pneumophila with the plasmid pSR47-ahpC::lux [72] and the E. coli
Tra+ helper strain RK600. Deletion mutants were complemented
with plasmid pJB1806M45, with either wild type or mutant
LEPR-effectors. Complementation strains were confirmed by
Western-blot analysis using antibodies specific to the protein
encoded by the complementation construct. Site-directed mutants
were made using complementary primers containing nucleotide
substitutions to generate the desired amino acid changes. After a
two-step PCR reaction to generate mutant plasmids, non-mutant
template DNA was removed by Dpn1 digestion. DNA was
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transformed into E. coli DH5a, and substitutions confirmed by
sequencing.
Mice and cell lines
The HEK293 FccRII GFP-Rab1 stable cell line was generated
by transfection of pcDNA-GFPRab1 followed by selection of
colonies using Zeocin (Invitrogen). The HEK293 FccRII
3XFLAG-Lpg1101 stable cell line was generated in a similar
manner to the GFP-Rab1 stable cell line using Zeocin selection at
400 mg/ml. HEK293 cells and stable variants were maintained as
described previously [5]. HeLa cells were maintained in DMEM
containing 10% FBS. HEK293 and HeLa cell transfections were
performed using Lipofectamine 2000 (Invitrogen) according to the
manufacturers instructions. C57BL/6 and A/J mice were
purchased from Jackson Laboratories. The laboratory of Pietro
De Camilli provided conditional PI4KIIIa knockout mice.
Animals were maintained in accordance with the Yale University
Institutional Animal Care and Use Committee (IACUC) under
protocol 2010-07847 approved May 15, 2012. Yale IACUC is
governed by applicable Federal and State regulations, including
those of the Animal Welfare Act, Public Health Service, and the
United States Department of Agriculture and is guided by the U.S.
Government Principles for the Utilization and Care of Vertebrate
Animals Used in Testing, Research and Training. Murine bone
marrow-derived macrophages were obtained from mice as
previously described [73], and used fresh or stored as described
[74]. For conditional knockout experiments bone marrow-derived
hematopoietic cells were induced for 3 to 4 days with L-cell
supernatant before addition of the vehicle control ethanol or 3 mM
(Z)-4-hydroxytamoxifen. Cells were supplemented on day 7 or 8
with 10 ml/10 cm dish of RPMI-1640 with 10% L-cell superna-
tant, 10% FBS and 1.5 mM tamoxifen. After 10-days cells were
visually inspected to confirm morphological changes (enhanced
size) associated with knockout, and seeded into 24-well plates in
media without drugs or antibiotics for infection the following day.
Knockout was assessed by western-blot analysis and phosphoino-
sitide analysis.
Infection of HEK293 FccRII cells and preparation of
microscopy samples
HEK293 FccII cells were seeded onto poly-L-lysine (MW
75,000–150,000; Sigma Aldrich) treated coverslips 24 h prior to
infection with opsonized bacteria at a multiplicity of infection (moi)
of 2. The bacteria were pre-complexed with a rabbit anti-Legionella
antibody (1:1000 or 1:2000) at 37uC for 20 min prior to infection.
Studies assessing localization of DrrA and Rab1 were assessed a
times indicated in figure legends or at 1 hour post-infection.
Infections were synchronized by spinning cells at 1000 rpm for
5 min, incubating for 30 min at 37uC and then washing three
times with warm PBS. Cells were fixed with 4% PFA for 10 min at
37uC. To ensure only internalized bacteria were analyzed for
recruitment of DrrA or Rab1, external L. pneumophila were stained
with rabbit Alexa Fluor 488 (1:3000) and then washed extensively
before cells were permeabilized using cold methanol. After
antibody staining with antibodies against effector proteins or
host-proteins and secondary Alexa Fluor 594 or Rhodamine Red-
X antibodies, 4,6-diamidino-2-phenylindole staining (DAPI) was
used to identify all bacteria. In experiments using the HEK293
FccII YFP-Rab1 stable cell line infections were performed with
dsRed expressing L. pneumophila strains and inside/out staining was
not performed. For infection experiments assessing the effect of
transiently expressed Sac1 on Rab1 recruitment to LCVs, Rab1
was detected by indirect immunofluorescence and the percentage
of FLAG-Sac1 transfected cells was assessed in each experiment by
staining separate coverslips with an anti-FLAG antibody. Only
experiments that achieved at least 75% transfection of Sac1 were
used to assess Rab1 recruitment. Analysis of endogenous Rab1
recruitment to vacuoles formed by wild type versus DsidF mutants
was performed using bacteria constitutively expressing GFP from
plasmid pAM239C, and Rab1 was detected by indirect immuno-
fluorescence. In all experiments coverslips were mounted using the
ProLong gold antifade reagent (Invitrogen).
Infection of bone marrow-derived macrophages (BMM)
For infections designed to assess localization of proteins during
infection of macrophages, BMMs were infected with L. pneumophila
strains expressing GFP at a multiplicity of infection of 2 or 20
using the synchronized infection protocol described earlier and
then incubated at 37uC for 1 hour. Cells were fixed and stained as
described for HEK293 cells, except that inside/out staining was
not performed. For growth assays, infections were performed as
described by Zamboni et al. (2006), using an moi of 0.01 [75]. The
fold differences were determined by dividing the values obtained at
48 h by the values obtained on day 0. Ex vivo growth assays were
repeated at least three times, and the results obtained were similar.
For BMM experiments using A/J mice L. pneumophila Lp01-derived
strains were used. For experiments using C57BL/6 and PI4KAflox
BMM, infections were performed using L. pneumophila JR32DflaA
[76].
Yeast growth assays
Lpg2603 was cloned into pYES2 (Invitrogen) and substitution
mutants created by site-directed mutagenesis. After sequencing,
plasmids were introduced into competent S.cerevisiae. Overnight
liquid YPD cultures were pelleted and washed once with water
before being diluted to an OD 600 nm of 1. Serial dilutions were
performed and 3 ml per dilution spotted onto either glucose or
galatose/raffinose plates. After 3 days incubation plates were
examined for yeast growth. Quantification of growth was
performed using Image J. For yeast protein expression analysis
yeast strains grown on YPD plates were used to inoculate
overnight (synthetic dextrose) SD broths with either glucose or
galactose/raffinose. Lysates were prepared by the glass bead
method in extraction buffer containing 100 mM DTT and
100 mM PMSF.
Protein purification
Affinity purification of tagged proteins was conducted as
described [8]. Proteins were dialyzed in buffer containing
50 mM Tris/HCl, pH 7.5, 150 mM NaCl, 1 mM DTT and
1 mM MgCl2 using dialysis cassettes (Slide-A-Lyzer, Thermo
Scientific) with a 20 kDa molecular mass cut-off. Protein
concentrations were assessed by absorbance at OD280 nm
accounting for the extinction coefficient, and then visually
confirmed by Coomassie blue staining.
PIP-strip analysis
PIP strips and arrays were purchased from Echelon Biosciences.
Proteins used for binding to membrane PIP strips were used at
1 mg/ml using the protocol suggested by Echelon Biosciences. For
PIP array binding, purified His-tagged proteins were added at
30 nM, and essentially fatty acid free BSA was used as a blocking
reagent.
Semi-permeabilized cell assay and inhibitors
For the semi-permeabilized cell assays, cells were treated with
digitonin as described [13]. After washing away the digitonin, 1 to
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5 mg/ml purified proteins (diluted in 125 mM K(OAc), 2.5 mM
Mg(OAc)2, 25 mM Hepes-KOH (pH 7.4), 1 mg/ml glucose,
1 mM DTT) were added to the wells and incubated with gentle
agitation for 1 hour at room temperature. This was followed by 2
washes of 1 ml each to remove unbound protein. Coverslips were
fixed in 4% PFA for 10 min and stained with appropriate
antibodies.
Antibodies
Rabbit polyclonal antibodies against GFP, calnexin and MBP
were purchased from Invitrogen, Stressgen and New England
Biolabs, respectively. Monoclonal antibodies to His and Flag were
from Sigma Aldrich, and the GM130 antibody from BD
Transduction laboratories. Rabbit polyclonal antibodies to Rab1A
and Rab1B were purchased from Santa Cruz. Rabbit polyclonal
antibodies to L. pneumophila and DrrA were described previously
[8]. Polyclonal antibodies against Lpg1101 and Lpg2603 were
produced at Cocalico Biologicals (Reamstown, PA) using affinity
purified histidine-tagged proteins as antigen to immunize the
rabbits. To affinity purify the antibodies raised against Lpg1101
and Lpg2603, 1 mg of the purified His-tagged proteins were run
on an SDS-page gel in a single lane spanning the entire gel width.
After transfer to nitrocellulose membrane, the portion of the
membrane with the correct migration size for the effector was cut
out and then incubated with 5 ml of anti-serum for 2 hours at
4uC. The membrane was washed 3 times with cold PBS for
10 minutes each and then cut into small pieces and transferred
into a 15 ml Falcon tube. 500 ml of 0.1 M Glycine (pH 2.5) was
added to the tube and the tube gently agitated for 10 minutes at
4uC. The recovered solution was neutralized with 200 mL of Tris
pH 8.8, dialyzed in cold PBS, and finally tested for specificity and
cross reactivity against bacterial and host cell lysates. The anti-
p115 and anti-PI4KIIIa antibodies were gifted by S. Mukherjee
and the laboratory of Pietro De Camilli, respectively. Two anti-
PI4KIIIb antibodies were used to check for a vacuolar PI4KIIIb
signal.
Sub-cellular fractionation
HEK293 FccII cells at 80% confluency in 6-well dishes were
transfected with 1 mg plasmid DNA per well with Lipofectamine
2000 (Invitrogen). After 16–24 h, cells were collected by centri-
fugation at 800 g, washed once in PBS, and resuspended in 500 ml
of buffer (0.25 M sucrose, 150 mM KCl, 20 mM Hepes-KOH,
2 mM EDTA, 1 mM PMSF, 1 mM DTT). Cells were homoge-
nized mechanically by repeatedly passing the suspension though a
27-gauge needle. After centrifugation at 1 700 g for 5 min the
supernatant fraction was centrifuged for 30 min at 100 000 g in a
Sorvall RC M120GX Ultracentrifuge. The resulting supernatant
fraction was collected, and the pellet washed once in PBS before
resuspension in SDS-page buffer. Equivalent amounts of super-
natant and membrane fractions were loaded onto polyacrylaminde
gels for separation and immunoblotting.
siRNA knockdown
siGENOME siRNA oligos were obtained from Dharmacon
(Thermo Scientific). Oligo sequences of individual siRNAs are
listed in supporting Text S1 (Table S4 in Text S1). HEK293 FccII
cells were seeded onto poly-L-lysine coated coverslips in 24-well
format. After 24 h cells were transfected with Lipofectamine 2000
and pools of four individual silencing reagents (A, B, C and D,
final 12.5 nM of each) and incubated for 72 hours before L.
pneumophila infection. Knockdown efficiency was validated by
quantitative RT-PCR using cDNA synthesized from total RNA
extracted from cells at 72 h post-knockdown. Primers used for
RT-PCR are listed in Text S1 (Table S5 in Text S1). Additional
details are available in the Materials and Methods section of
supporting Text S1.
Phosphoinositide analysis
Phosphoinositide analysis was performed as described previous-
ly [77]. Data were shown as the mean ratio of PI4P to PI(4,5)P2
levels (peak areas), which represent the bulk of PIP2 and PIP
respectively, from three independent experiments.
Microscopy
Epifluorescence micrographs were taken using a TE2000
(Nikon) inverted microscope and this microscope was used for
all counting experiments. Confocal micrographs showing locali-
zation of ectopically expressed effectors were taken using a
LSM510 microscope (Zeiss) with a 1006/1.4 numerical aperture
objective, or a Fluoview FV10i (Olympus) microscope with a 606/
1.35 numerical aperture objective.
Statistical analysis
To statistically assess significance, calculations were performed
using the paired Student’s t-test (homoscedastic two-tailed, paired)
using Excel software (Microsoft). In all graphs error bars represent
standard error of the mean (SEM).
Gene accession numbers
The genes described in this manuscript are lpg1101, lpg2603 and
drrA with Genbank accession numbers of YP_095134.1,
YP_096608.1 and YP_096471.1, respectively.
Supporting Information
Figure S1 LEPR-containing proteins are Dot/Icm effec-
tors that bind PM-derived organelles. (A) Graph showing
Cya-based assay for translocation of effector proteins into host
cells. CHO FccRII cells were infected with L. pneumophila strains
wild type (grey bars) or DdotA (black bars) harboring plasmids
expressing Cya fusion with the indicated proteins. One hour after
infection cells were lysed and cAMP was extracted and quantified.
Levels of cAMP were also determined for cells infected with wild-
type L. pneumophila expressing Cya alone (pCya). Each bar
represents the mean cAMP value obtained from triplicate wells
+/2 standard error of the mean (SEM). (B) Coomassie-stained
SDS-page gel of proteins from an in vitro binding assay to assess
role of the LEPR in effectors binding to Rab1. GST-Rab1 was
bound to Glutathione beads and then incubated with His-tagged
wild-type DrrA or Lpg1101. After washing away unbound protein,
proteins were eluted from the GST-beads, boiled and then
analyzed by Coomassie staining. Unlike DrrA, the LEPR
containing Lpg1101 protein was unable to bind to GST-Rab1 at
a level detectable by this assay. (C) Representative images of the
localization of the various GFP-DrrA constructs in HEK293
FccRII cells. Separate panels show endogenous staining of the
Golgi maker GM130. DrrA containing the GEF and PI4P-binding
domains (amino acids 201–647) localizes to both the Golgi and
PM. However, the GEF domain alone (201–500) is sufficient for
Golgi localization. The PI4P-binding domain of DrrA (501–647)
shows predominantly PM localization. This region is also the
minimal region found to bind to plasma-membrane syntaxins (see
Figure S3), however without the PI4P-binding region (amino acids
451–545) PM targeting does not occur. (D) Confocal xy images of
HEK293 FccRII cells transfected with constructs expressing GFP-
DrrA or EYFP-Lpg1101 or EYFP-Lpg2603 or mutant protein
variants, and RFP-PALM. (E) Summary of GFP- or YFP-tagged
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truncation constructs tested for localization to the PM in HEK293
FccRII cells. Unshaded (white) constructs did not show plasma
membrane (PM) localization. Constructs shaded grey or black
gave a PM signal. In grey are the minimal C-terminal domain
constructs that gave a PM signal.
(TIF)
Figure S2 Intracellular growth analysis of single and
triple LEPR mutants. Defects in intracellular replication of
single or the triple LEPR mutants were not observed in
macrophages or in amoeba. (A) Fold change in colony forming
units over 72 hours of L. pneumophila strains in A/J bone marrow-
derived macrophages with an MOI of 1. Results are from two
independent experiments, with triplicate wells in each experiment.
(B) Graph showing fold change in relative luminescence units
(RLU) of lux-expressing L. pneumophila strains in THP-1 cells using
a 96-well plate format. Results shown are from two independent
experiments as indicated and represent the average of 8–12 wells
per assay. (C) Fold change in colony forming units over 48 hours
of L. pneumophila strains in Acanthamoeba castellani with an MOI of 1.
Data represent the average from two independent experiments
performed in triplicate.
(TIF)
Figure S3 Lpg1101 and Lpg2603 are functionally dis-
tinct compared to DrrA. Western-blot images showing co-
immunoprecipitation of (A) GFP-tagged DrrA 200–500, 451–647,
501–647, 451–545 or 546–647, or (B) EYFP-tagged-Lpg1101 or
EYFP-tagged 2603 proteins and FLAG-tagged SNARE proteins
produced in HEK293 FccRII cells. Interactions were examined
after precipitation of the SNARE proteins from cells extracts using
anti-FLAG agarose. The antibodies indicated to the right of each
blot show protein levels in the blots of the lysate (2.5–4% of input)
and blots of the immunoprecipitate (IP). (C) Representative
fluorescent micrographs (1006) of CHO FccRII cells co-
transfected with EYFP-Rab1a and mRFP-Lpg1101 or mRFP-
LPg2603. The blue fluorescence is from 49,6-diamidino-2-
phenylindole (DAPI) staining.
(TIF)
Figure S4 The LEPR is important for localization to the
PM. (A) Table summarizing the localization of EYFP-Lpg2603
site-mutants assessed by epifluorescence microscopy in HEK293
FccRII cells. (B) Examples from summary table A. Epifluorescent
micrographs of CHO FccRII cells transfected with EYFP-
Lpg2603 and mutant derivatives G354A and D355E,K358R.
Shown in red is phalloidin staining. Arrows indicate fluorescence
overlap between peripheral actin (phalloidin) and Lpg2603. (C)
Representative images of HEK293 cells expressing GFP-tagged
DrrA constructs 61–647, 451–647 and the minimal PM
localization region 501–647. Data shows the effect of single and
double amino acid substitutions at positions 565 and 568 within
DrrA.
(TIF)
Figure S5 The MIM domain is important for PM-
localization of DrrA. Micrographs of confocal Z-stacks of
ectopically expressed GFPDrrA501–647 and lysine mutant variants
(L610A, L614/615A, L617A, L610/614/615A, L614/615/716A,
L610/614/615/617A) in HEK293 cells. Cells were co-transfected
with mTagRFPPALM.
(TIF)
Figure S6 The MIM domain is important for PM-
localization of Lpg1101. Micrographs of confocal Z-stacks of
ectopically expressed EYFPLpg1101 and alanine mutant variants
(L610A, L614/615A, L617A, L610/614/615A, L614/615/716A,
L610/614/615/617A, K246A/T297A) in HEK293 cells. Closed
white arrows indicate areas of peripheral membrane localization.
(TIF)
Figure S7 PI4P is present on the LCV. (A) Fluorescent
micrographs showing localization of FAPP1 PH domain contain-
ing GFP fusion proteins in HEK293 FccR cells infected with
dsRed expressing wild-type (Lp02) or DdotA (Lp03) L. pneumophila
for 30 min. (B) Fluorescent micrographs showing localization of
GFP-FAPP1 and GFP-FAPP1R18L in HEK293 FccR cells
infected with dsRED-expressing L. pneumophila for 45 min. Cells
were semi-permeabilized before fixation as described in supple-
mentary methods. We were unable to visualize endogenous PI4P
on vacuoles using the anti-PI4P antibody (Echelon biosciences).
(C) Uninfected HEK293 cells transfected with YFP- or GFP-
tagged LEPR effectors and variants, and semi-permeabilized
before fixation. Blue color is DAPI staining.
(TIF)
Figure S8 The LEPR in DrrA is important for in vivo
function. (A) Micrographs of HEK293 FccRII cells infected with
various Legionella pneumophila Philadelphia-1 strains at 1 hour post-
infection stained with DrrA-specific antibodies and DAPI. Strains
that do not produce DrrA (DdrrA) or produce DrrA containing
mutations that perturb PI4P-binding (DdrrA +pJBdrrA
K568A,T619A) fail to show vacuolar DrrA signals. (B) Micro-
graphs of EYFP-Rab1 dynamics during infection with strains
expressing WT DrrA or DrrA D565E,K568R visualized using
spinning disc microscopy. YFP-Rab1a HEK293 FccR cells were
infected with L. pneumophila stained with CellTracker Orange,
images of infection were obtained every 50 seconds. Gallery
contains images of projected confocal stacks displayed at the
specified timepoints post-infection. Both merge and YFP-Rab1
channels are displayed to facilitate comparison of Rab1 levels on
the vacuole. White arrowheads indicate a bacterium that becomes
internalized during the course of imaging. (C) In vitro binding assay
to assess influence of the C-terminal mutations on binding of DrrA
to Rab1. GST-Rab1S25N (dominant negative) and GST-
Rab1Q70L (constitutive active) were bound to Glutathione beads
and then incubated with His-tagged wild type or mutant DrrA.
After washing away unbound protein, proteins were eluted from
the GST-beads, boiled and then analyzed by Western-blotting. All
DrrA proteins were able to bind to GST-Rab1S25N (GDP-locked)
with similar levels. (D) Western-blots showing translocation of
DrrA during infection is not inhibited by expression of DrrA from
a plasmid in trans or by site-mutations within the C-terminal PI4P
domain. DrrA present in the bacterial pellet and cellular debris
versus cell lysate on hour after infection of HEK293 FccRII cells
was assessed using the DrrA specific antibody. The plasma
membrane protein syntaxin 3 is shown as a loading control for
lysates and the process of cell lysis and fractionation.
(TIF)
Figure S9 Analysis of translocated Lpg1101 and
Lpg2603 localization during infection using indirect
immunofluorescence. (A) Western-blot analysis of Lpg1101
and Lpg2603 production in wild type, mutant and complemented
L. pneumophila strains. Antibodies raised against His-tagged
Lpg1101 and Lpg2603 was used to probe lysates of L. pneumophila
grown to late exponential/early stationary phase on CYE media.
Levels of the bacterial heat shock protein 60 (Hsp60) are shown
as a loading control. (B) Fluorescent micrograph of bone
marrow-derived macrophage from an A/J mouse infected with
wild type Lp01 at 30 minutes post-infection. DNA is stained with
DAPI, and the localization of Lpg1101 assessed using an affinity
purified anti-lpg1101 antibody. (C) Fluorescent micrographs of L.
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pneumophila at 8 hours post infection in HeLa cells. Rabbit anti-
Lpg2603 (1:300) staining is shown in red, and mouse anti-Legionella
(1:5000) is shown in green. The wild type, Dlpg2603 and
complemented strains posses vacuoles containing replicating
bacteria, whereas singles bacteria were found in the DdotA infected
cells. Vacuolar localization of Lpg2603 was not observed in the
DdotA or Dlpg2603 mutant strains, however both the complement-
ed strains examined, irrespective of the PI4P-binding capacity of
the Lpg2603 proteins produced, localized to vacuoles containing
replicating bacteria.
(TIF)
Figure S10 Semi-permeabilized cell system to examine
LEPR domain localization. (A) Epifluorescent images of
HEK293 FccRII cells treated with digitonin and then incubated
with purified His-tagged proteins DrrA, Lpg1101 and Lpg2603
from Legionella pneumophila or with a non-LEPR containing
bacterial protein (His-SteC from Salmonella enterica serover
Typhimurium). After washing away non-bound protein, proteins
were detected using an anti-His antibody. (B) Micrographs
showing localization of HisDrrA D565E/K568R, and HisDrrA
K568A/T619A in semi-permeabilized cell system as in (A). Note
that purified DrrA, with mutations that perturb PI4P-binding,
show Golgi-localization. This is consistent with targeting due to
Rab1-binding (see Figure S1C). (C) Fractionation of HEK293 cells
after addition of His-DrrA, HisDrrA D565E/K568R, K568A/
T619A in the semi-permeabilized cell system. The lower blot
shows detection of Syntaxin 3 (Stx3) as a membrane fraction
control. (D) Representative micrographs showing results of semi-
permeabilized assay to assess the influence of ionomycin on
localization of purified His-DrrA, His-Lpg1101, and His-Lpg2603.
(TIF)
Figure S11 SidC localizes to the Golgi-apparatus in a
PI4KIIIb-dependent manner. Epifluorescent images of
HEK293 FccRII cells treated with digtonin and then incubated
with purified MBP-Lpg2603134–434 or MBPSidC609–776. After
washing away non-bound protein, proteins were detected using an
anti-MBP antibody. When indicated cells were preincubated with
1 mM PIK93 for 30 min prior to digitonin treatment. PIK93 was
also maintained throughout the protein binding step. PIK93 causes
a change in the localization of the Golgi-localized PI4P-binding
probe from SidC but not the PM-localized Lpg2603 probe.
(TIF)
Figure S12 Controls for siRNA knockdown and cre-
mediated deletion of PI4KIIIa in Pi4kaflox –derived cells.
(A) Quantification of SidC-recruitment to vacuoles formed by wild
type or DsidF mutant L. pneumophila expressing GFP (+pAM239C)
in HEK FccRII cells after 1 hour of infection. Fluorescent
micrographs show representative staining pattern of SidC used
for analysis. (B) Anion-exchange HPLC of glycerol-inositol
phosphates obtained from control and knockout BMM. Data
shown are the mean ratio of PI4P to PI(4,5)P2 levels (peak areas),
which represent the bulk of PIP2 and PIP respectively, from three
independent experiments. (C) Western-blot showing protein levels
of PI4KIIIa at day 7 after TMX (tamoxifen) treatment or EtOH
(ethanol vehicle control) treatment. Also shown is the level of the
protein p115. (D) The extent of knockdown of PI4KIIIa and
PI4KIIIb mRNA by siRNA in HEK293 FccRII cells was assessed
by RT-PCR on cDNA obtained from mRNA extracted from cells
on day 3. For each sample, transcript levels of genes targeted for
silencing were compared to transcript levels of GAPDH. Results
shown are the average of three independent experiments, and are
presented as the percent of transcript detected relative to mock
controls. (E) Representative micrographs taken with an epifluor-
escent microscope using a 606objective showing BMDM infected
with GFP expressing L. pneumophila. Asterisks indicated LCVs
scored positive for Rab1 recruitment.
(TIF)
Text S1 Supplementary information including Tables
S1–S5, and additional methods and references for
supporting figures. Tables S1–S3 list the bacterial strains,
plasmids and primers used in this study, respectively. Table S4
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